-+ 0.00%
-+ 0.00%
-+ 0.00%

Conference Call: Alkermes Sees Q3 Sales $450.000M-$470.000M vs $472.751M Est

Benzinga·07/28/2026 13:06:02
Listen to the news
Alkermes (NASDAQ:ALKS) sees Q3 sales of $450.000 million-$470.000 million vs $472.751 million analyst estimate.